Zobrazeno 1 - 10
of 41
pro vyhledávání: '"D G, Tinkelman"'
Autor:
J R, Jowers, A L, Schwartz, D G, Tinkelman, K E, Reed, P R, Corsello, A A, Mazzei, D R, Bender, R A, Lochhead
Publikováno v:
The American journal of managed care. 6(5)
To show that a disease management program that empowers patients with asthma to participate in the management of their condition can improve quality of life and reduce the use of medical services.Utilization and quality-of-life data were tracked to i
Autor:
D G, Tinkelman
Publikováno v:
Pediatrics. 102(1 Pt 2)
Publikováno v:
The Journal of allergy and clinical immunology. 101(4 Pt 1)
National and international guidelines recommend the use of inhaled antiinflammatory medications in patients with all but the mildest forms of asthma. Twice daily dosing may increase compliance with therapy.We sought to evaluate the safety and efficac
Publikováno v:
The Journal of allergy and clinical immunology. 101(1 Pt 1)
Inhaled corticosteroids and oral theophylline are effective treatments for moderate asthma.We sought to compare the benefits and adverse reactions of theophylline and aerosol beclomethasone spray.A multicenter, double-blind, double-placebo, randomize
Publikováno v:
The Journal of asthma : official journal of the Association for the Care of Asthma. 31(3)
Pirbuterol is a selective beta-2 adrenergic agonist that is indicated for the treatment of bronchospasm in patients with asthma. Traditionally, the most common form of administration of the beta-2 agonist is by inhalation from a pressurized metered-d
Publikováno v:
Annals of allergy. 70(4)
Seven children were evaluated who had recurrent sinusitis, acute otitis media, pneumonia, and mastoiditis. All children had normal or near normal levels of IgG, IgA, and IgM. One child displayed a poor antibody response following tetanus and diphther
Publikováno v:
Pediatrics. 90(4)
Autor:
J P, Kemp, I L, Bernstein, C W, Bierman, J T, Li, S C, Siegel, R D, Spangenberg, D G, Tinkelman
Publikováno v:
Annals of allergy. 68(6)
Pemirolast is a new oral, nonbronchodilator antiallergy medication that is being evaluated for the therapy of asthma. In this multicenter, double-blind, randomized study, 96 patients with mild asthma received pemirolast, 50 mg (n = 34); pemirolast, 2
Autor:
D G, Tinkelman, C, Lutz
Publikováno v:
Annals of allergy. 68(1)
In this investigation we evaluated the effect of increasing dosage, using an inhaled beta-2 specific agonist, pirbuterol, administered by a metered dose inhaler on pulmonary function, tremor, and cardiovascular parameters in nonacute adult asthmatic
Autor:
R B, Berkowitz, D G, Tinkelman
Publikováno v:
Annals of allergy. 67(6)
This study was a single center trial comparing the effects of the nonsedating antihistamine terfenadine, at a dose of 120 mg twice a day, with placebo in the treatment of rhinitis symptoms associated with the common cold. Forty-nine subjects were tre